OrbiMed Advisors »

CryoLife shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of CryoLife (AORT) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in CryoLife

Tip: Access up to 7 years of quarterly data

All positions including CryoLife held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CryoLife by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.5M 151k 36.62

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Avita Therapeutics (RCEL)
Mdxhealth Sa Shs New Call Option (MDXH)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Boston Scientific Corporation (BSX)
Sionna Therapeutics (SION)
Astrazeneca Ord (AZN)
Myriad Genetics (Principal) (MYGN)
Mbx Biosciences (MBX)
Corvus Pharmaceuticals (CRVS)
Argenx Se Sponsored Adr (ARGX)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)

View all positions for OrbiMed Advisors

Top funds holding CryoLife

BlackRock
FMR
Nomura Asset Management International
Morgan Stanley
Vanguard Capital Management
State Street Corporation
Perceptive Advisors
Conestoga Capital Advisors
Fred Alger Management
Juniper Investment Company
Wellington Management Company
Geode Capital Management
Vanguard Portfolio Management
Dimensional Fund Advisors
Next Century Growth Investors

View all funds holding CryoLife